A natural history of melanoma: serial gene expression analysis.
about
A balanced review of the status T cell-based therapy against cancerRNA amplification for successful gene profiling analysis.Reflections upon human cancer immune responsiveness to T cell-based therapyMolecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma.Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in OncologyA systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers".Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy.Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?The role of quantitative PCR for the immune monitoring of cancer patients.Molecular signatures induced by interleukin-2 on peripheral blood mononuclear cells and T cell subsetsVaccination with T cell-defined antigens.A genetic inference on cancer immune responsivenessNew take on comparative immunology: relevance to immunotherapy.Gene-expression profiling in vaccine therapy and immunotherapy for cancerProspective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness.IL-10 stimulatory effects on human NK cells explored by gene profile analysis.The challenge of studying complex diseases undergoing complex treatments: the metastatic cancer model.The trouble with translational medicine.Turning laboratory findings into therapy: a marathon goal that has to be reached.
P2860
Q24800636-71B72035-129B-46BA-9803-BF552BFF38CCQ24812532-89E06696-684B-4642-8780-753724AF83E8Q27004674-F51C0256-B2BB-41C1-A1AA-35AC4F3B5F89Q30423599-A3858A53-824C-464E-86F4-03ABDF31E3F7Q30438965-070DE04B-F43A-4E68-9C1C-766E952B8F74Q30440347-8D3472FC-9B25-4326-A58E-D3FD6F38363FQ33479314-0FC2177B-E99F-4139-8D91-653E7F56C2BEQ34669820-2E7E1165-71AB-4C0D-BA69-C46A0B89A1D4Q34701413-39EFA25F-24A1-486C-9E81-42F17ADC91D8Q35012607-A58F771E-4243-4751-A66A-89768DB585D8Q35779384-43BD6494-D661-4BB4-89CB-CDA83D6CEC87Q36057497-ADA207B6-4ECB-4D4E-B40F-AA3D781B6CEAQ36126352-311A5F6F-72FA-4509-A5CA-5697A08F3B8DQ36138329-B9914910-C427-4B49-848A-9F882D31366BQ36456711-249208D1-8845-4F62-9323-14D2F24ED1E9Q38333675-DC6515CB-4B56-4923-89F4-B5199BF97F79Q46156982-2EBF1DCE-5501-42FB-84E0-9D457C66C799Q51867234-9803690C-57FC-4FD9-8582-46E2BCDC1E44Q54956643-871A19F3-2177-4627-ABEE-770A35F59255
P2860
A natural history of melanoma: serial gene expression analysis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A natural history of melanoma: serial gene expression analysis.
@ast
A natural history of melanoma: serial gene expression analysis.
@en
A natural history of melanoma: serial gene expression analysis.
@nl
type
label
A natural history of melanoma: serial gene expression analysis.
@ast
A natural history of melanoma: serial gene expression analysis.
@en
A natural history of melanoma: serial gene expression analysis.
@nl
prefLabel
A natural history of melanoma: serial gene expression analysis.
@ast
A natural history of melanoma: serial gene expression analysis.
@en
A natural history of melanoma: serial gene expression analysis.
@nl
P1433
P1476
A natural history of melanoma: serial gene expression analysis.
@en
P2093
P304
P356
10.1016/S0167-5699(00)01724-2
P577
2000-12-01T00:00:00Z